Superficial siderosis of the central nervous system: Response to steroid therapy

Journal of Neurology

Volumn 249, Issue 9, 2002, Pages 1223-1225

  Angstwurm, Klemens ^a   Schielke, E ^a   Zimmer, C ^a   Kivelitz, D ^a   Weber, J R ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; RI ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DISEASE COURSE; HUMAN; MALE; MEDICAL EXAMINATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SIDEROSIS; STEROID THERAPY; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MALE; METHYLPREDNISOLONE; SIDEROSIS;

EID: 0036037731     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0815-0     Document Type: Article

References (8)

1. Non-transferrin-bound iron and cellular toxicity
2. Superficial siderosis of the CNS: MR diagnosis and clinical findings
3. Inhibition of microglial superoxide production by isoproterenol and dexamethasone
4. Inhibition of microglial cell activation by cortisol
5. Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus
6. The pathogenesis of superficial siderosis of the central nervous system
7. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
8. Polyradiculopathy in the course of superficial siderosis of the CNS